SCHEMBL5199837

SCHEMBL5199837

CCc1cccc(CC(=O)c2cccc(Br)c2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
PARP1 P09874 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
ALDH1A1 P00352 4/20 0.43
GLA P06280 1/20 0.43
MAPT P10636 2/20 0.43
RECQL P46063 1/20 0.43
RAB9A P51151 1/20 0.43
GRM5 P41594 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
NPC1 O15118 1/20 0.42
MGAM O43451 1/20 0.42
AMY1A P0DUB6 1/20 0.42
GAA P10253 1/20 0.42
SI P14410 1/20 0.42
MGAM2 Q2M2H8 1/20 0.42
RXFP1 Q9HBX9 1/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5199273 0.87 GRM5 (0.55) TSHRNPSR1PARP1L3MBTL1ALDH1A1
SCHEMBL5943286 0.84 PARP1 (0.44) TSHRNPSR1PARP1L3MBTL1ALDH1A1
SCHEMBL4428289 0.77 TDP1 (0.47) TSHRNPSR1PARP1L3MBTL1ALDH1A1
SCHEMBL2203444 0.75 PARP1 (0.59) TSHRNPSR1PARP1L3MBTL1ALDH1A1
SCHEMBL11636011 0.75 KDM4E (0.55) TSHRL3MBTL1ALDH1A1GLAMAPT
SCHEMBL6134112 0.74 NPC1 (0.45) TSHRPARP1L3MBTL1ALDH1A1GLA
SCHEMBL30758864 0.73 PARP1 (0.61) PARP1L3MBTL1ALDH1A1GLAMAPT
SCHEMBL8193355 0.72 TSHR (0.45) TSHRNPSR1PARP1L3MBTL1ALDH1A1
SCHEMBL27626615 0.72 PARP1 (0.52) PARP1L3MBTL1ALDH1A1GLAMAPT
SCHEMBL931177 0.72 MAPT (0.57) PARP1L3MBTL1ALDH1A1GLAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275968-A1 Substituted Biphenyl Derivative SANKYO COMPANY, LIMITED (JP) 2007-11-29 US disclosed
EP-1798229-A1 SUBSTITUTED BIPHENYL DERIVATIVE Sankyo Company, Limited (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275968-A1 Substituted Biphenyl Derivative COL2A1, COL1A1, FGFR3 TSHR 556/4885NPSR1 1454/4885PARP1 2604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.